In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...
19h
Dr. Mehmet Oz holds millions of dollars worth of shares in health insurance, fertility, pharmaceutical and vitamin companies.
The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...
DelveInsight's Transmucosal Drugs Market Insights report provides the current and forecast market analysis, individual leading transmucosal drugs companies' market shares, challenges, transmucosal ...
Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-Jae Lee), a leading healthcare company in Korea, announced the ...
AbbVie's combination antibiotic Emblaveo has gotten federal approval to treat complicated intra-abdominal infections, making it the first and only such therapy approved to fight antimicrobial ...
The global Global Pharmaceutical Chemicals Market is expected to grow at 7.2% CAGR from 2025 to 2032. The global Global Pharmaceutical Chemicals Market Report offers an in-depth analysis of the ...
I can’t believe the stock dropped so much. I think AbbVie is a buy.” AbbVie Inc. (NYSE:ABBV) is a pharmaceutical company involved in the research, development, production, and promotion of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback